Key Team Members
SANQUIN, ITALIAN NATIONAL BLOOD CENTRE, ETABLISSEMENT FRANCAIS DU SANG, NHS BLOOD AND TRANSPLANT, CSL PLASMA GMBH, AARHUS UNIVERSITETSHOSPITAL, SIHTASUTUS POHJA-EESTI REGIONAALHAIGLA, BANC DE SANG I TEIXITS, BLUTSPENDEDIENST DES BAYERISCHEN ROTEN KREUZES GGMBH, UNIVERSITY OF CAMBRIDGE, BIOEF FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS, SUOMEN PUNAINEN RISTI, MINISTRY FOR HEALTH MALTA, ZAVOD REPUBLIKE SLOVENIJE ZA TRANSFUZIJSKO MEDICINO, OSTERREICHISCHES ROTES KREUZ, UNIVERSITAETSKLINIKUM HAMBURG EPPENDORF, VIESOJI ISTIAGA NACIONALINIS KRAUJO CENTRAS
In cooperation with the partners involved, the WP5 Leader will produced Guidelines for SoHO donor selection and protection, including some guiding principles. The methodology that will be used for the development of the document will consist of evaluations of donation-related risks and critical reviews of existing and emerging eligibility criteria, aiming for risk-based, tailored, flexible and consistent donor eligibility criteria.
Work Package Leader of WP5 – Development of donor selection & protection guidelines in TRANSPOSE. Chief physician and professor at Institute for Clinical Medicine, University of Copenhagen. Founder of The Danish Blood Donor Study. Head of The Biobank Unit and The Virology Section at Department of Clinical immunology, Rigshospitalet.
I am currently working and training as a specialist in Clinical Immunology in the Blood bank, the Department of Clinical Immunology, Copenhagen University Hospital. My main areas of interests are blood donor safety and haemovigilance and alongside my daily work I am a member of the Danish Registration of Transfusion Risks. My role in TRANSPOSE is local coordination of WP5 and the WP's deliverables.
Transpose project news
- February 21, 2020
- November 27, 2019
- August 8, 2019
- May 13, 2019